Explore Global Companies & Account Intelligence

Founded in 1947 by Arthur Conference Goatham, our family business is now run by his son Clive and grandson Ross. We’re proud of being British, passionate about our countryside roots and have strong family values that have stood the test of time. Looking after our orchards from one generation to the next. Ross’ two sons, though too young to be making career choices, love spending time in the orchards, and are already showing interest in becoming the fourth generation. Our growing business has been all about the British apples and pears and has grown from two farms to currently farming 3000 acres of top quality British fruit. We have been supplying supermarkets since the 1980's and have acquired close relationships with Sainsbury’s, Aldi, Iceland and Morrison’s. In addition to our own production of around 55,000 tonnes of fruit each year we also work with a number of partner growers. Our future lies in sticking to what we have always done and done best. Growing Great British.

AC Group har til huse i Viborg og har det formål at understøtte de overordnede retningslinjer for strategi, kommunikation, økonomi og IT for koncernens selskaber. Vi er med til at skabe og understøtte en stærk kultur, der udvikler og styrker fællesskabet på tværs af selskaberne i AC Group. I erkendelse af, at omverdenen udvikler sig i et fortsat hastigere tempo, søger AC Group at have øje for de eksterne markedsvilkår og -tendenser, der kan give vores selskaber en konkurrencemæssig fordel. AC Group ønsker kort sagt at være koncernens væksthus og strategiske knudepunkt med fokus på innovation, dynamik og udvikling.

AC Group rappresenta una rete di società che si occupa di formazione, consulenza e ingegneria. La formazione specialistica è rivolta a tutte le realtà aziendali dellindotto industriale con particolare riferimento alle imprese del settore dei trasporti. Il nostro team di professionisti è in grado di condurre il cliente in un percorso di crescita per ottimizzare risorse e processi grazie a una attività di consulenza continua e costante. Il nostro pool di ingegneri affianca le aziende nel gestire con facilità e convenienza il processo relativo alla manutenzione dei veicoli e a perseguire, in maniera strutturata, lefficacia e lefficienza dei processi.

Comprehensive enterprise dossier available in global intelligence registry.

AC Immune SA is a clinical-stage biopharmaceutical company and a global leader in precision prevention for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen® and Morphomer®, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features sixteen therapeutic and diagnostic programs, including five in Phase 2 development and one in Phase 3. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies, resulting in substantial non-dilutive funding to advance its proprietary programs and >$4.5 billion in potential milestone payments plus royalties.

AC Immune SA is a clinical-stage biopharmaceutical company and a global leader in precision prevention for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen® and Morphomer®, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features sixteen therapeutic and diagnostic programs, including five in Phase 2 development and one in Phase 3. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies, resulting in substantial non-dilutive funding to advance its proprietary programs and >$4.5 billion in potential milestone payments plus royalties.

AC Immune SA is a clinical-stage biopharmaceutical company and a global leader in precision prevention for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen® and Morphomer®, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features sixteen therapeutic and diagnostic programs, including five in Phase 2 development and one in Phase 3. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies, resulting in substantial non-dilutive funding to advance its proprietary programs and >$4.5 billion in potential milestone payments plus royalties.

AC Immune SA is a clinical-stage biopharmaceutical company and a global leader in precision prevention for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen® and Morphomer®, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features sixteen therapeutic and diagnostic programs, including five in Phase 2 development and one in Phase 3. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies, resulting in substantial non-dilutive funding to advance its proprietary programs and >$4.5 billion in potential milestone payments plus royalties.

AC Immune SA is a clinical-stage biopharmaceutical company and a global leader in precision prevention for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen® and Morphomer®, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features sixteen therapeutic and diagnostic programs, including five in Phase 2 development and one in Phase 3. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies, resulting in substantial non-dilutive funding to advance its proprietary programs and >$4.5 billion in potential milestone payments plus royalties.

Comprehensive enterprise dossier available in global intelligence registry.

AC Landscapes & Treeworks UK Ltd originally started as AC Landscape & Treeworks in 2007 with just two men. Which over the past few years has grown the business into 3 separate companies under the umbrella of the AC Landscapes & Treeworks UK Ltd. The group consists of AC Landscapes & Treeworks, AC Garage Services and AC Training. AC Landscapes & Treeworks UK Ltd has worked extremely hard to achieve several accreditations and be apart of many scheme's throughout its subsidary companies. The accreditations that have been brought to these businesses are as follows; Approved Contractor of the Arb Association, ISO9001 & ISO14001, Sector Schemes 18 & 12D, CHAS, Good Garage Scheme, Exor, Safe Contractor and Work Safe Contractor. Head Office: Broadway Road Kingsteignton Newton Abbot TQ12 3PJ Tel: 01626 355238 West Mids Regional Office: Regus Building Central Boulevard Blythe Valley Business Park Birmingham B90 8AG Tel: 01564 711648

Ac Management Solutions nasce dallesigenza di creare un soggetto consulenziale di riferimento per la piccola e media impresa, matrice fondante della realtà produttiva italiana. Lobiettivo è fornire anche alle piccole e medie imprese quegli strumenti di supporto, propri delle grandi multinazionali della consulenza aziendale, convenzionalmente riservati alla grande industria. Professionisti qualificati e con specifiche esperienze di settore convergono per costruire e strutturare una solida base di azione, oggi irrinunciabile in un mercato che non concede margine di errore.